Sanofi delivered close to double-digit Q4 2020
The Pharma Data
FEBRUARY 8, 2021
Vaccines up 14.6%, driven by record demand for differentiated influenza vaccines and continued growth of PPH. to €36,041 million, driven by Dupixent ® (€3,534 million, up 73,9%) and Vaccines. We continue to work in parallel on our two COVID-19 vaccine candidates, with clinical trials starting in the coming weeks.
Let's personalize your content